Skip to main content
SpringerLink
Log in

Amylin increases bone volume but cannot ameliorate diabetic osteopenia

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Amylin is normally secreted in a regulated fashion by the pancreatic β-cells in parallel with insulin and has been reported to have bone-conserving properties. Type I diabetes mellitus results in a low-turnover osteopenia in the presence of decreased amylin, which is in contrast to type II diabetes where less bone loss, in the presence of high amylin levels, occurs. We investigated the effects of amylin on bone mineral metabolism in normal and dibetic (streptozotocin-induced) rats, in order to ascertain whether amylin would modify the streptozotocin-induced diabetic osteopenia. Tenweek-old male Sprague-Dawley rats were randomized as follows: group A (n=18) received normal saline; group B (n=18) received amylin; group C, diabetic rats (n=23), received normal saline; and group D, diabetic rats (n=23), received amylin. Amylin (100 pmol/100 g b. w.) was administered by a daily subcutaneus injection. Double calceinlabeled tibiae were removed for histomorphometric analysis followed sacrifice on day 19. Results showed no difference in blood ionized calcium between groups. Blood glucose remained above 600 mg/dl in the diabetic animals and was not affected by the administration of amylin. Serum osteocalcin, insulin-like growth factor-1 (IGF-1), parathyroid hormone (PTH), and 1,25 dihydroxyvitamin D [1,25(OH)2D] were significantly lower in the diabetic rats compared with control group A by day 19. Amylin produced higher levels of serum osteocalcin in group B on day 9 (P<0.05) compared with controls but returned to control values (group A) by day 19; no such change occurred in the diabetic group. Amylin administration did not influence IGF-1, 1,25(OH)2D or PTH levels compared with the untreated animals. Analysis of the bone histomorphometry showed a low-turnover osteopenia in the diabetic animals. Amylin administration resulted in a significant increase in bone volume in the normal rats, group B (P<0.05), but was unable to significantly alter this parameter in the diabetic animals. In conclusion, amylin has a beneficial effect on the bone metabolism of the rat in vivo by increasing bone volume. It is, however, unable to overcome the osteopenia caused by streptozotocin-induced diabetes mellitus at the doses used in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Verhaeghe J, Suiker AMH, Nyomba BL, Visser WJ, Einhorn TA, Dequeker J, Bouillon R (1989) Bone mineral homeostasis in spontaneously diabetic BB rats. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology 124:573–582

    Google Scholar 

  2. Verhaeghe J, Van Herck E, Visser J, Suiker AMH, Thomasset M, Einhorn TA, Faierman E, Bouillon R (1990) Bone and mineral metabolism in BB rats with long-term diabetes. Diabetes 39:477–482

    Google Scholar 

  3. Levin ME, Boisseau VC, Avioli LV (1976) Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 294:241–245

    Google Scholar 

  4. Auwerx J, Dequeker J, Bouillon R, Geusens P, Nijs J (1988) Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes 37:8–12

    Google Scholar 

  5. Epstein S (1989) Diabetes mellitus and abnormalities of bone and collagen metabolism In: LeRoith D, Drazin M, Melmed S (eds) Molecular and cellular biology of diabetes mellitus, complications of diabetes mellitus ed vol III. Allan R Liss, Inc. New York, pp 115–124

    Google Scholar 

  6. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84:3881–3885

    Google Scholar 

  7. Asai J, Nakazato M, Kangawa K, Matsukura S, Matsuo H (1989) Isolation and sequence determination of rat islet amyloid peptide. Biochem Biophys Res Commun 164:400–405

    Google Scholar 

  8. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ, Porte D (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by B-cells. Diabetes 39:634–638

    Google Scholar 

  9. Moore CX, Cooper GJS (1991) Co-secretion of amylin and insulin from cultured islet β-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents. Biochem Biophys Res Commun 179:1–9

    Google Scholar 

  10. Zaidi M, Datta HK, Wimalawansa SJ, MacIntyre I (1990) Amylin-amide: a new bone-conserving peptide from the pancreas. Exp Physiol 75:529–536

    Google Scholar 

  11. Tamura T, Miyaura C, Owan I, Suda T (1992) Mechanism of action of amylin in bone. J Cell Physiol 153:6–14

    Google Scholar 

  12. Cooper GJS, Willis AC, Clark A, Tuner RC, Sim RB, Reid KB (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628–8632

    Google Scholar 

  13. Roberts AN, Leighton B, Todd JA, Cockburn D, Schofield PN, Sutton R, Holt S, Boyd Y, Day AJ, Foot EA, Willis AC, Reid KBM, Cooper GJS (1989) Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc Natl Acad Sci USA 86:9662–9666

    Google Scholar 

  14. MacIntyre I (1989) Amylinamide, bone conservation, and pancreatic β cells. Lancet 8670:1026–1027

    Google Scholar 

  15. Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DA (1988) An islet amyloid is derived an 89-amino acid precursor by proteolytic processing. J Biol Chem 263:17243–17246

    Google Scholar 

  16. Cooper GJS, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuck JM, Howland K, Rothbard JB, Willis AC, Reid KBM (1988) Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci USA 85: 7763–7766

    Google Scholar 

  17. Leighton B, Cooper GJS (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in-vivo. Nature 335:632–635

    Google Scholar 

  18. Permert J, Larsson J, Westermark GT, Herrington MK, Christmanson L, Pour PM, Westermark P, Adrian TE (1994) Islet amyloid in patients with pancreatic cancer and diabetes. N Engl Med 330(5):313–318

    Google Scholar 

  19. van Jaarsveld BC, Hackeng WHL, Nieuwenhuis MG, Erkelens DW, Geerdink RA, Lips CJM (1990) Islet-Amyloid polypeptide in human plasma (letter). Lancet 335:60

    Google Scholar 

  20. Butler PC, Chou J, Bradford Carter W, Wang Y, Bu B, Chang D, Chang J, Rizza RA (1990) Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39:752–756

    Google Scholar 

  21. Clark A, Cooper GJS, Lewis CE, Morris JF, Willis AC, Reid KBM, Turner RC (1987) Islet amyloid formed from diabetes-associated peptide may be pathogenic in type 2 diabetes. Lancet 8554:231–234

    Google Scholar 

  22. Glajchen N, Epstein S, Thomas S, Fallon M, Chakrabarti S (1988) Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling. Endocrinology 123:290–295

    Google Scholar 

  23. Ogawa A, Harris V, McCorkle SK, Unger RH, Luskey KL (1990) Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment. J Clin Invest 85:973–976

    Google Scholar 

  24. Jacobs TW, Takizawa M, Liu CC, Berlin JA, Katz IA, Stein B, Joffe II, Cooper GJS, Epstein S (1992) Amylin stimulates bone cell turnover in vivo in normal and diabetic rats. J Bone Miner Res 7(1):S226

    Google Scholar 

  25. Price PA, Lothringer JW, Nishimoto SK (1980) Absence of the vitamin k-dependent bone protein in fetal rat mineralization: evidence for another gamma-carboxyglutamic acid-containing component of bone. J Biol Chem 255:2938–2942

    Google Scholar 

  26. Toverud SV, Boass A, Garner SC, Endres DB (1986) Circulating parathyroid hormone concentrations in normal and vitamin D-deprived rat pups determined with N-terminal-specific radioimmunoassay. Bone 1:145–155

    Google Scholar 

  27. Reinhardt TA, Horst RL, Orf JW, Hollis BW (1986) A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 58:91–98

    Google Scholar 

  28. Bala RM, Bhaumick B (1979) Radioimmunoassay of a basic somatomedin: comparisons of techniques and somatomedin levels in various sera. J Clin Endocrinol Metab 49:770–777

    Google Scholar 

  29. Crawford BA, Martin JL, Howe CJ, Handelsman DJ, Baxter RC (1993) Comparison of extraction methods for insulin-like growth factor-I in rat serum. J Endocrinol 134:169–176

    Google Scholar 

  30. Liu CC, Kalu DN (1990) Human parathyroid hormone-(1–34) prevents bone loss and augments formation in sexually mature ovariectomized rats. J Bone Miner Res 5:973–982

    Google Scholar 

  31. Villanueva AR (1988) A new Goldner's one-step trichome stain for identification of osteoid seams, bone and cells in undecalcified plastic-embedded sections of bone. J Histotechnology 11: 249–252

    Google Scholar 

  32. Liu CC, Baylink DJ, Wergedal JE, (1975) Immobilization and its effects on bone repletion in calcium-deficient rats fed on a high calcium diet. Metab Bone Dis Rel Res 1:269–276

    Google Scholar 

  33. Schajowicz F, Cabrini RL (1959) Histochemical demonstration of acid phosphatase in hard tissues. Stain Technol 34:59–64

    Google Scholar 

  34. Joffe I, Katz I, Jacobs T, Stein B, Takizawa M, Liu C, Berlin J, Epstein S (1992) 17β-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A. Endocrinology 130:1578–1586

    Google Scholar 

  35. Epstein S, Takizawa M, Stein B, Katz IA, Joffe II, Romero DF, Liang XG, Ke HZ, Jee WSS, Jacobs TW, Berlin J (1994) The effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat. J Bone Miner Res 9:557–566

    Google Scholar 

  36. Graubert MD, Goldstein D, Phillips LS (1991) Total and free IGF-1 and IGF binding proteins in rats with streptozotocin-induced diabetes. Diabetes 40:959–965

    Google Scholar 

  37. Gilbey SG, Ghatei MA, Bretherton-Watt D, Zaidi M, Jones PM, Perera T, Beacham J, Girgis S, Bloom SR (1991) Islet amyloid polypeptide: production by an osteoblast cell line and possible role as a paracrine regulator of osteoclast function in man. Clin Sci 81:803–808

    Google Scholar 

  38. Ismail F, Epstein S, Fallon MD, Thomas SB, Reinhardt TA (1988) Serum bone gla protein and the vitamin D endocrine system in the oophorectomized rat. Endocrinology 122:624–630

    Google Scholar 

  39. McCarthy TL, Centrella M, Canalis E (1989) Regulatory effects of insulin-like growth factor 1 and 11 on bone collagen synthesis in rat calvarial cultures. Endocrinology 124:301–309

    Google Scholar 

  40. Schlechter NL, Russell SM, Spencer M, Nicoll CS (1986) Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 83:7932–7934

    Google Scholar 

  41. Wimalawansa SJ, Gunasekera RD, Datta HK (1992) Hypocalcemic actions of amylin amide in humans. J Bone Miner Res 7:1113–1116

    Google Scholar 

  42. Alam ASMT, Moonga BS, Bevis PJR, Huang HJS, Zaidi M (1991) Selective antagonism of calcitonin-induced osteoclastic quiescence (Q-effect) by human calcitonin gene-related peptide-(Val8 Phe37) Biochem Biophys Res Commun 179:134–139

    Google Scholar 

  43. Alam ASMT, Bax CMR, Shankar VS, Bax BE, Bevis PJR, Huang HJS, Moonga BS, Pazianas M, Zaidi M (1992) Further studies on the mode of action of calcitonin on isolated rat osteoclasts: pharmacological evidence for a second site mediated intracellular Cas2+ mobilization and cell retraction. J Endocrinol 136:7–15

    Google Scholar 

  44. Alam ASMT, Moonga BS, Bevis PJR, Huang HJS, Zaidi M (1993) Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts. Exp Physiol 78:183–196

    Google Scholar 

  45. Datta HK, Zaidi M, Wimalawansa SJ, Ghatei MA, Beacham JL, Bloom SR, MacIntyre I (1989) In-vivo and in-vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit. Biochem Biophys Res Commun 162:876–881

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Albert Einstein Medical Center, 5401 Old York Road, 19141, Philadelphia, Pennsylvania, USA

    B. Rucinski, J. A. Isserow, F. J. Buchinsky, M. Cvetkovic & S. Epstein

  2. American Lake VA Medical Center, 98493, Tacoma, Washington

    C. C. Liu

  3. Department of Medicine, University of Washington, 98195, Seattle, Washington, USA

    C. C. Liu

Authors
  1. D. F. Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. P. Bryer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Rucinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. A. Isserow
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. J. Buchinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Cvetkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. C. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Epstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

These investigators should be viewed as having contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romero, D.F., Bryer, H.P., Rucinski, B. et al. Amylin increases bone volume but cannot ameliorate diabetic osteopenia. Calcif Tissue Int 56, 54–61 (1995). https://doi.org/10.1007/BF00298745

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00298745

Key words

Search

Navigation